On the basis of previous experiences indicating that the anti-oxidant
agent Cu/Zn superoxide dismutase (SOD) is an effective drug in reducin
g acute and late radiation-induced tissue injury, in the Center of Rad
iotherapy and Oncology of Catalonia, Barcelona, Spain in 1990 we imple
mented a randomized prospective study to analyze the incidence and gra
de of side effects in a group of bladder cancer patients. After surger
y patients were randomly allocated to receive either: Option A: Radiot
herapy or Option B: Radiotherapy + SOD 8mgr/IM/day, after each radioth
erapeutic application. Between January 1990 and January 1995 a total o
f 448 patients were included (226A/222B). Apart from cutaneous side ef
fects, a highly significant incidence of radioinduced acute cystitis a
nd rectitis was detected in patients not treated by SOD. Which was sim
ilar to the delayed side effects. From our data we can conclude that S
OD is effective in decreasing acute radioinduced damage, and also in p
reventing the appearance of more delayed disorders.